January 16, 2017 — Fujifilm Medical Systems has informed the U.S. Food and Drug Administration (FDA) of its plans to remove its legacy 250/450 duodenoscope models from clinical use. This is based on the limited number currently in use and issues related to reprocessing of these devices leading to reports of multi‐drug resistant bacteria on endoscopes used for endoscopic retrograde cholangiopancreatogram (ERCP) procedures.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now